Suzetrigine - Wikipedia
Suzetrigine, sold under the brand name Journavx, is a medication used for the management of pain. [1] [2] It is a non-opioid, small-molecule analgesic that works as a selective inhibitor of …
FDA Approves Novel Non-Opioid Treatment for Moderate to …
3 days ago · Today, the U.S. Food and Drug Administration approved Journavx (suzetrigine) 50 milligram oral tablets, a first-in-class non-opioid analgesic, to treat moderate to severe acute …
FDA Approves Journavx (suzetrigine), a First-in-Class Treatment …
Journavx (suzetrigine) is a first-in-class, oral, non-opioid, highly selective pain signal inhibitor that is selective for NaV1.8 relative to other NaV channels. NaV1.8 is a voltage-gated sodium …
Vertex Announces FDA Approval of JOURNAVX™ (suzetrigine), a …
4 days ago · About JOURNAVX™ (suzetrigine) JOURNAVX (suzetrigine) is a first-in-class, oral, non-opioid, highly selective pain signal inhibitor that is selective for NaV1.8 relative to other …
FDA approves first new type of pain medication in 25 years
3 days ago · Suzetrigine is a pill that’s given in two dosages. In studies, participants got an initial dose of 100 milligrams, followed by 50 milligrams every 12 hours.
FDA Approves Journavx Drug to Treat Pain Without Addiction Risk …
3 days ago · Suzetrigine’s price, though, is much higher than that of acetaminophen plus hydrocodone. Patients are expected to take two pills a day, for a total cost of $31 a day.
FDA Approves the First Non-Opioid Pain Medicine in 20 Years
3 days ago · On Jan. 30, the U.S. Food and Drug Administration (FDA) approved a new drug called suzetrigine to treat moderate-to-severe pain. The prescription pills, sold under the brand …
New Pain Medication Suzetrigine Prevents Pain Signals from …
Aug 20, 2024 · In January 2024 Vertex announced promising results of clinical trials of VX-548, which it is calling suzetrigine, showing that it dampened acute pain levels by about one half on …
Suzetrigine (Journavx), an Opioid Alternative for Pain - GoodRx
3 days ago · Suzetrigine (Journavx) is a non-opioid pain medication. It’s an oral tablet that treats moderate-to-severe acute (short-term) pain in adults. This opioid alternative works by blocking …
US drug agency approves potent painkiller — the first non
3 days ago · Suzetrigine, now given the brandname Journavx, is not the first sodium channel-targeting drug to be used for pain management. Compounds such as procaine (Novocain) and …